Top Sepsis Diagnostics companies

The 5 key players our Sepsis Diagnostics report profiles, and other companies free public records show in this market.

Key players in Sepsis Diagnostics

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Also active in Sepsis Diagnostics

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Also active in Sepsis Diagnostics, from free public records
CompanyWhere public records show them
AstraZeneca
Artcline GmbH
ImmunityBio, Inc.
Bayer AG
CorMedix Therapeutics
Bluejay Diagnostics, Inc.

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Top trial sponsors in Sepsis Diagnostics

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. AstraZeneca 3 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Artcline GmbH 3 active trials on ClinicalTrials.gov (opens in a new tab)
  3. ImmunityBio, Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Bayer AG 2 active trials on ClinicalTrials.gov (opens in a new tab)
  5. CorMedix Therapeutics 2 active trials on ClinicalTrials.gov (opens in a new tab)
  6. Bluejay Diagnostics, Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Sepsis Diagnostics reports by place

All 33 places for Sepsis Diagnostics

Get the full Sepsis Diagnostics report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.